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co the Editor: Implantable cardioverter-defibrillators (ICDs) re-
uce sudden cardiac death. However,25% of patients with ICDs
re shocked in the last month of life (1), and these shocks may
ause frightening and painful deaths. Little is known about how
hysicians’ attitudes influence their decisions to discuss ICD
eactivation with patients.
We created a simple random sample of the American Medical
ssociation Masterfile by choosing 100 physicians from each of 4
trata: electrophysiologists, cardiologists, geriatricians, and inter-
ists. Eligible clinicians had to be in active practice and had to have
ared for at least 1 patient with an ICD. We mailed letters to all
hysicians introducing the study, and then followed up by tele-
hone to administer the survey. Physicians who could not be
ontacted by telephone were mailed surveys, and a series of
ncentives was used to encourage participation. All surveys were
nonymous. This project was exempt from review by the Mount
inai School of Medicine Institutional Review Board.
We based the survey on our previous qualitative work (2,3). The
nstrument included Likert scales—from 1 (strongly disagree) to 5
strongly agree)—to determine physicians’ attitudes relating to
CD conversations (Table 1). Data were analyzed as both contin-
ous and dichotomous variables. As the results of these analyses
ere similar, the Likert scales are reported as strongly agree or
gree versus all others. For between-group comparisons, the
hi-square test was used; the Fisher exact test was used for smaller
ell sizes. The p values reflect comparisons across the 4 groups.
here was no difference in response patterns between phone and
ritten surveys. Analysis of variance was used to evaluate the
ifferences in age of respondents across the 4 groups. Significance
evels for individual tests were not adjusted as the survey was based
n our previous data and the sample size was small, thus making it
nlikely that any observed association would be due to chance
lone (4). All calculations were performed using SAS version 9.0
SAS Institute, Cary, North Carolina).
Of the 400 physicians selected for the survey, 11 were deemed
neligible (7 were retired and 4 had never cared for a patient with
n ICD) and 52 could not be located. Of the remaining 337
ligible physicians, 147 completed surveys, yielding a response rate
mong physicians who could be located of 44% (147 of 337).
lectrophysiologists had a higher response rate (58%) compared
ith cardiologists (36%), internists (37%), and geriatricians (41%;
 0.013). Geriatricians tended to be older than cardiologists,
lectrophysiologists, or internists (mean age 54.1 years vs. 48.3,
9.0, and 48.1 years, respectively; p  0.001). The likelihood of
eing male was higher among electrophysiologists (92%) and oardiologists (93%) than among geriatricians (62%) and internists
66%; p  0.001).
Clinicians’ views about care for seriously ill patients with ICDs
aried across specialty. Electrophysiologists were less likely than
ardiologists, internists, or geriatricians to agree/strongly agree that
hey could accurately predict the possibility of a patient being
hocked by the ICD near the end of life (12% vs. 41%, 46%, and
0%, respectively; p 0.005). With respect to patient understand-
ng, 94% of electrophysiologists and 93% of cardiologists who
esponded strongly agreed/agreed with the statement that their
atients understood why they had an ICD, whereas only 74% of
nternists and 77% of geriatricians agreed with this statement (p 
.03). Sixty-three percent of electrophysiologists, 45% of cardiol-
gists, 33% of internists, and 55% of geriatricians believed patients
new they could deactivate their ICD (p  0.11).
One potential barrier to ICD deactivation discussions may
elate to physician’s beliefs that they can predict which patients will
eceive a shock. In reality, it can be difficult to predict the terminal
ardiac rhythm. Physicians who believe they can predict who will
e shocked may fail to discuss deactivation with patients for whom
hey mistakenly believe ICD firing is unlikely.
Clinicians may be unaware of patients’ understanding about
heir devices. Most clinicians in every group believed their patients
nderstood the indication for their device, which might limit their
elief that more discussion is needed. Data from patient focus
roups, however, reveal that patients do not know the indication
or their device and that their understanding of its purpose varies
idely and is often inaccurate (2).
A final barrier may be that many physicians (in our study, 1 of
of internists and 2 of 3 of electrophysiologists) believed that
atients already knew they could deactivate the shocking function
f their ICD. Prior data suggest that patients with ICDs often do
ot know that this is possible (2). Clinicians who believe that
atients know the options for device management at the end of life
ay be less likely to have deactivation conversations.
This study has limitations. The rate of surveys completed was
50%. Nevertheless, our enrollment rate is consistent with other
linician surveys reporting on patients with advanced illness (5).
lectrophysiologists were more likely to respond as compared with
thers, perhaps because they take more “ownership” of the issue of
eactivation because it involves a device they implant.
This study identifies clinician perceptions that may reflect
arriers to communication about deactivation of ICDs in patients
ith advanced illness. The focus of this work is on barriers to
onversations, because we believe that these conversations should
ccur as part of conversations about advance care planning;
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July 21, 2009:371–4esults of 5-Point Likert Scales to Determine Physicians’ Attitudes Relating to Care of Patients With ICDsTable 1 Results of 5-Point Likert Scales to Determine Physicians’ A titudes Relating o Care of Patients With ICDs
Cardiologists Electrophysiologists Geriatricians Internists p Value
I feel confident in my clinical skills in dealing with
patients at the end of life.
Agree 25 (86) 41 (84) 35 (97) 25 (83) 0.17*
Neutral/disagree 4 (14) 8 (16) 1 (3) 5 (17)
I feel comfortable with my skills in communicating
with patients about treatment options near
the end of life.
Agree 26 (90) 43 (88) 35 (100) 27 (90) 0.14*
Neutral/disagree 3 (10) 6 (12) 0 (0) 3 (10)
A bad experience with a past conversation about
ICD deactivation makes me reluctant to have
future conversations about deactivation with
patients.
Agree 2 (8) 0 (0) 1 (7) 0 (0) 0.18*
Neutral/disagree 24 (92) 45 (100) 13 (93) 10 (100)
I feel confident that I can reasonably estimate a
patient’s life-expectancy.
Agree 8 (28) 15 (31) 12 (35) 11 (42) 0.68
Neutral/disagree 21 (72) 33 (69) 22 (65) 15 (58)
I am confident that I can accurately predict the
possibility of a patient being shocked by the
ICD near the end of life.
Agree 12 (41) 6 (12) 9 (30) 11 (46) 0.005
Neutral/disagree 17 (59) 43 (88) 21 (70) 13 (54)
I believe that my role is to make the decision for a
patient in terms of the best medical
treatments.
Agree 11 (38) 16 (33) 18 (50) 16 (53) 0.25
Neutral/disagree 18 (62) 32 (67) 18 (50) 14 (47)
I believe that my role is to solely inform patients
of their treatment options and then let them
make the decision on their own.
Agree 16 (55) 20 (41) 18 (51) 18 (60) 0.37
Neutral/disagree 13 (45) 29 (59) 17 (49) 12 (40)
I believe that my role is to work with the patient to
share decision making about the best
treatments.
Agree 27 (93) 44 (92) 32 (89) 28 (93) 0.93*
Neutral/disagree 2 (7) 4 (8) 4 (11) 2 (7)
I think that my patients understand why they have
an ICD.
Agree 27 (93) 46 (94) 27 (77) 20 (74) 0.03*
Neutral/disagree 2 (7) 3 (6) 8 (23) 7 (26)
I think that my patients know that if they so
choose, they can deactivate the portions of
their ICD that may cause discomfort to
them (i.e., cardioversion or defibrillation
functions).
Agree 13 (45) 31 (63) 17 (55) 7 (33) 0.11
Neutral/disagree 16 (55) 18 (37) 14 (45) 14 (67)
I feel that I have adequate time to be able to
discuss treatments with patients.
Agree 23 (77) 33 (67) 19 (54) 14 (48) 0.09
Neutral/disagree 7 (23) 16 (33) 16 (46) 15 (52)
Uncertainty about a patient’s prognosis prevents
me from engaging in conversations about
ICD deactivation.
Agree 10 (33) 12 (24) 4 (13) 6 (24) 0.34*
Neutral/disagree 20 (67) 37 (76) 26 (87) 19 (76)
I only feel comfortable having conversations about
ICD deactivation with patients with whom I
have a well-established relationship.
Agree 11 (38) 22 (46) 14 (44) 6 (29) 0.57
Neutral/disagree 18 (62) 26 (54) 18 (56) 15 (71)
Positive experiences with past ICD deactivation
discussions have encouraged me to have
these conversations with my patients.
Agree 13 (54) 29 (62) 10 (63) 6 (55) 0.90
Neutral/disagree 11 (46) 18 (38) 6 (38) 5 (45)Continued on next page
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July 21, 2009:371–4hether the device is deactivated is the decision of the patient and
amily. Because patients with ICDs are cared for by physicians of
variety of specialties with differing views, future interventions to
mprove conversations about device deactivation should be targeted
o both specialists and generalists, with the appropriate timing of
hese conversations determined by subsequent empirical studies.
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or this work. This research is supported by Dr. Nathan Goldstein’s Mentored
ontinuedTable 1 Continued
Cardiologists
If a patient is hospitalized frequently, I am/would
be more inclined to discuss deactivation with
him/her.
Agree 11 (37)
Neutral/disagree 19 (63)
If a patient has worsening organ function, I am/
would be more inclined to discuss
deactivation with him/her.
Agree 25 (83)
Neutral/disagree 5 (17)
alues are n (%). Clinicians were asked to rate these statements on a scale of 1 to 5, where 1 was “
n reporting these data, the investigators report the Likert scales as strongly agree or agree (noted
here was no mention about an implantable cardioverter-defibrillator (ICD) in a particular statem
omparisons across the 4 groups of clinicians. All results were obtained using the chi-square test,
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ardiac Intensive Care Unit
oised for Real Time?
trict glucose control has been promoted in many intensive care
nit (ICU) settings, including the cardiac ICU, because of the
otion that this will “lower the risk of mortality in critically ill
atients” (1). However, enthusiasm should be tempered by a
ealization that the landmark trial showing benefit is wrought withrom such a strategy. Ceriello et al. (1) assert that “strong evidence
or tight glycemic control as a key strategy for improving prognosis
fter acute coronary syndromes comes from the study by Van den
erghe et al.” (2). However, this study was done on surgical
atients, and the greatest decrease in mortality occurred in patients
ith sepsis. Additionally, concerns have been raised regarding
ncharacteristically high mortality rates in the control group and
or the concomitant use of a high-dose glucose infusion and
arenteral nutrition (3), which is not a standard practice strategy
4). Ceriello et al. (1) also cite beneficial findings of strict glucose
ontrol in the medical ICU (5), without noting that comparisonsEl
strongl
in Tab
ent, tn this trial were made with historical controls, making it difficult
